Effect of Real-time Computer-aided System (ENDO-AID) on Adenoma Detection in Endoscopist-in-training (ENDOAIDTRAIN)

February 6, 2023 updated by: Louis Ho Shing Lau, Chinese University of Hong Kong

Effect of Real-time Computer-aided System (ENDO-AID) on Adenoma Detection in Endoscopist-in-training: a Single-blind Randomized Study

The investigator's hypothesis is that a CADe system (ENDO-AID) would improve the adenoma detection rate in junior endoscopists.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Colorectal cancer (CRC) is the most common and second most lethal cancer in Hong Kong with more than 5,600 new cases and 2,300 deaths annually. Colonoscopy with polypectomy has shown to reduce CRC-related mortality by 53%. However, high polyp miss rates were reported to be up to 26% for adenomas and 9% for advanced adenomas in standard colonoscopies. Risk factors included proximal location, serrate or flat lesions, poor bowel preparation and short withdrawal time (<6 minutes). Insufficient trainee experience was also associated with a higher adenoma miss rate. A significant proportion of interval CRC was attributed to the missed lesions during index colonoscopy leading to adverse patient outcomes.

As a result, various techniques were developed to improve adenoma detection rate (ADR) during colonoscopies. Techniques including water exchange method, second examination of the right colon (retroflexion or second forward view)and cap/cuff-assisted colonoscopies were proven to increase ADR effectively. However, these techniques were operator-dependent requiring certain level of expertise.

Recently, artificial intelligence and computer-aided polyp detection (CADe) systems have developed rapidly around the globe. These systems can provide real-time CADe by flagging the suspected lesions to endoscopists, with the adoption of deep learning or convoluted neural networks. A number of prospective randomized clinical trials reported a significant increase in ADR in CADe group. The number of adenoma detected per colonoscopy was consistently higher among different polyp sizes, location and morphology. The ADR increment was particularly higher for diminutive adenomas smaller than 5mm.

Nevertheless, most of the aforementioned studies only involved senior endoscopists for the procedures. Theoretically, the senior endoscopists were more skillful to expose colonic mucosa and more experienced to distinguish the false positive computer signals, leading to an enhanced performance of CADe in real-time colonoscopies. The effect of CADe on inexperienced junior endoscopists performing colonoscopies remains largely unknown.

In this single-blind randomized study, the investigators aim to evaluate the effect of a new CADe system (ENDO-AID) on adenoma detection and quality improvement in junior endoscopists.

Study Type

Interventional

Enrollment (Actual)

856

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New Territories
      • Shatin, New Territories, Hong Kong
        • Prince of Wales Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Aged 18 years old or above;
  2. They require elective colonoscopy for colorectal cancer screening, polyp surveillance, or investigation of symptoms such as anemia or gastrointestinal bleeding;
  3. Written informed consent obtained.

Exclusion Criteria:

  1. Contraindication to colonoscopy (e.g. intestinal obstruction or perforation)
  2. Contraindication or conditions precluding polyp resection (e.g. active gastrointestinal bleeding, significant bleeding tendency, uninterrupted anticoagulation or dual antiplatelets)
  3. Scheduled staged procedure for polypectomy or biopsy
  4. Previous colonic resection
  5. Personal history of colorectal cancer
  6. Personal history of polyposis syndrome
  7. Personal history of inflammatory bowel disease
  8. Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above)
  9. Pregnancy
  10. Unable to obtain informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention arm
CADe system will be used during withdrawal phase of colonoscopy.
ENDO-AID CADe will be used during the withdrawal process of the colonoscopy.
NO_INTERVENTION: Control arm
Colonoscopy will be performed according to hospital protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ADR
Time Frame: During the colonoscopy
adenoma detection rate
During the colonoscopy

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ADR for adenomas of different sizes
Time Frame: During the colonoscopy
<5mm, 5-10mm, >10mm
During the colonoscopy
ADR for adenomas of different colonic segments
Time Frame: During the colonoscopy
caecum, ascending colon, hepatic flexure, transverse colon, splenic flexure, descending colon, sigmoid colon, rectum
During the colonoscopy
Mean number of adenomas per colonoscopy
Time Frame: During the colonoscopy
Mean number of adenomas per colonoscopy
During the colonoscopy
Advanced adenoma detection rate
Time Frame: During the colonoscopy
Advanced adenoma detection rate
During the colonoscopy
Polyp detection rate
Time Frame: During the colonoscopy
Polyp detection rate
During the colonoscopy
Withdrawal time
Time Frame: During the colonoscopy
excluding interventions
During the colonoscopy
Total procedural time
Time Frame: During the colonoscopy
Total procedural time
During the colonoscopy
False positive rate
Time Frame: During the colonoscopy
defined as computer artifacts due to colonic mucosal wall or bowel content lasting for >2 seconds
During the colonoscopy
Sessile serrate lesion (SSL) detection rate
Time Frame: During the colonoscopy
Sessile serrate lesion (SSL) detection rate
During the colonoscopy
Non-neoplastic resection rate
Time Frame: During the colonoscopy
defined as absence of adenoma or SSL within resected specimen
During the colonoscopy
Missed polyp rate
Time Frame: During the colonoscopy
defined as a polyp which the junior endoscopist fails to recognize and withdraws the endoscope to next colonic segment, but detected by the supervisor
During the colonoscopy
Cecal intubation time
Time Frame: During the colonoscopy
Cecal intubation time
During the colonoscopy
Percentage of change in ADR in relation to the personal experience in colonoscopy
Time Frame: During the colonoscopy
Percentage of change in ADR in relation to the personal experience in colonoscopy based on number of procedures performed <200 vs 200-500
During the colonoscopy

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 19, 2021

Primary Completion (ACTUAL)

July 22, 2022

Study Completion (ACTUAL)

December 31, 2022

Study Registration Dates

First Submitted

March 23, 2021

First Submitted That Met QC Criteria

April 7, 2021

First Posted (ACTUAL)

April 9, 2021

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2023

Last Update Submitted That Met QC Criteria

February 6, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2021.141

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no plan to share individual participant data to other researchers

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Screening Colonoscopy

Clinical Trials on ENDO-AID CADe

Subscribe